Work

Efficacy and Safety of Ravagalimab in Patients With Moderate-to-Severe Ulcerative Colitis: Data From a Phase 2a Trial

Year: 2026
Type: article
Abstract: The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
Source: Figshare
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7143445331
FWCI:
Cites:
Cited by:
Related to: 10